Sorafenib treatment for recurrent stage T1 bilateral renal cell carcinoma in patients with Von Hippel-Lindau disease: A case report and literature review

被引：7
作者：
Choi, Kyung Hwa [1 ]
Yu, Young Dong [1 ]
Kang, Moon Hyung [1 ]
Park, Dong Soo [1 ]
机构：
[1] CHA Univ, CHA Bundang Med Ctr, Dept Urol, Songnam, South Korea
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2015年 / 9卷 / 9-10期
关键词：
SUNITINIB; PATTERNS; THERAPY;
D O I：
10.5489/cuaj.2863
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Renal cell carcinoma (RCC) with Von Hippel-Lindau (VHL) syndrome is associated with multiple recurrences and a young age at diagnosis. Therefore the primary goal of treatment is to stabilize the disease, minimizing the surgical resection and preserving the renal function in the patients with VHL who have developing RCC nodules after initial treatment. This is the first case report of VHL disease, with long-term stable disease, treated with a half dose of sorafenib after surgical resection and radiofrequency ablation for multiple recurrent stage T1 masses. We discuss the efficacy and safety of low-dose sorafenib treatment and review RCC in a patient with VHL disease.
引用
收藏
页码：E651 / E653
页数：3
相关论文
共 12 条
  • [1] Renal cancer in von Hippel-Lindau disease and related syndromes
    Bausch, Birke
    Jilg, Cordula
    Glaesker, Sven
    Vortmeyer, Alexander
    Luetzen, Niklas
    Anton, Alexandra
    Eng, Charis
    Neumann, Hartmut P. H.
    [J]. NATURE REVIEWS NEPHROLOGY, 2013, 9 (09) : 529 - 538
  • [2] Friedrich CA, 1999, CANCER-AM CANCER SOC, V86, P2478, DOI 10.1002/(SICI)1097-0142(19991201)86:11+<2478::AID-CNCR4>3.3.CO
  • [3] 2-X
  • [4] Oncological Outcomes of Partial Nephrectomy for Multifocal Renal Cell Carcinoma Greater Than 4 cm
    Gupta, Gopal N.
    Peterson, James
    Thakore, Kailash N.
    Pinto, Peter A.
    Linehan, W. Marston
    Bratslavsky, Gennady
    [J]. JOURNAL OF UROLOGY, 2010, 184 (01) : 59 - 63
  • [5] Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease
    Jonasch, E.
    McCutcheon, I. E.
    Waguespack, S. G.
    Wen, S.
    Davis, D. W.
    Smith, L. A.
    Tannir, N. M.
    Gombos, D. S.
    Fuller, G. N.
    Matin, S. F.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (12) : 2661 - 2666
  • [6] IDENTIFICATION OF THE VONHIPPEL-LINDAU DISEASE TUMOR-SUPPRESSOR GENE
    LATIF, F
    TORY, K
    GNARRA, J
    YAO, M
    DUH, FM
    ORCUTT, ML
    STACKHOUSE, T
    KUZMIN, I
    MODI, W
    GEIL, L
    SCHMIDT, L
    ZHOU, FW
    LI, H
    WEI, MH
    CHEN, F
    GLENN, G
    CHOYKE, P
    WALTHER, MM
    WENG, YK
    DUAN, DSR
    DEAN, M
    GLAVAC, D
    RICHARDS, FM
    CROSSEY, PA
    FERGUSONSMITH, MA
    LEPASLIER, D
    CHUMAKOV, I
    COHEN, D
    CHINAULT, AC
    MAHER, ER
    LINEHAN, WM
    ZBAR, B
    LERMAN, MI
    [J]. SCIENCE, 1993, 260 (5112) : 1317 - 1320
  • [7] Patterns of intervention for renal lesions in von Hippel-Lindau disease
    Matin, Surena F.
    Ahrar, Kamran
    Wood, Christopher G.
    Daniels, Molly
    Jonasch, Eric
    [J]. BJU INTERNATIONAL, 2008, 102 (08) : 940 - 945
  • [8] Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease
    Ploussard, Guillaume
    Droupy, Stephane
    Ferlicot, Sophie
    Ples, Racula
    Rocher, Laurence
    Richard, Stephane
    Benoit, Gerard
    [J]. UROLOGY, 2007, 70 (03) : 435 - 439
  • [9] Molecular aberrations, targeted therapy, and renal cell carcinoma: current state-of-the-art
    Randall, J. Michael
    Millard, Frederick
    Kurzrock, Razelle
    [J]. CANCER AND METASTASIS REVIEWS, 2014, 33 (04) : 1109 - 1124
  • [10] First-Line sunitinib in patients with renal cell carcinoma (RCC) in von Hippel-Lindau (VHL) disease: clinical outcome and patterns of radiological response
    Roma, Anna
    Maruzzo, Marco
    Basso, Umberto
    Brunello, Antonella
    Zamarchi, Rita
    Bezzon, Elisabetta
    Pomerri, Fabio
    Zovato, Stefania
    Opocher, Giuseppe
    Zagonel, Vittorina
    [J]. FAMILIAL CANCER, 2015, 14 (02) : 309 - 316
12